Markets › India › NSE › PPLPHARMA

Piramal Pharma Ltd

NSE:PPLPHARMAHealthcareNSE:CNX500NSE:CNXPHARMA

₹194.44−1.66%At closeAt close · Mon 19 Oct · ≈ AED 7.51 · Market cap $2.77B · Next earnings Tue 27 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	56.8%	58.6%	57.3%	59.8%	60.6%	26.9%	—	—
Operating margin	16.6%	5.6%	−0.7%	5.7%	7.5%	1.0%	1.0%	+0.0 pts
Net margin	19.7%	5.8%	−2.7%	0.2%	1.0%	−3.7%	−3.7%	+0.0 pts
EBITDA margin	30.8%	19.5%	12.7%	16.9%	18.2%	11.2%	—	—
Return on equity	13.9%	5.6%	−2.8%	0.2%	1.1%	−4.0%	−4.0%	+0.0 pts
Return on assets	9.9%	2.9%	−1.3%	0.1%	0.6%	−1.8%	−1.8%	+0.0 pts
Return on capital employed	11.2%	3.7%	−0.4%	4.2%	5.7%	0.7%	—	—
Debt / equity	0.0×	0.6×	0.8×	0.6×	0.6×	0.7×	0.7×	+0.0%
Debt / assets	3.0%	32.3%	38.8%	30.8%	31.0%	31.6%	—	—
Interest coverage	102.0×	1.8×	−0.1×	1.0×	1.6×	0.3×	—	—
Current ratio	1.2×	1.3×	1.3×	1.3×	1.5×	1.5×	1.5×	+0.0%
Quick ratio	0.9×	0.9×	0.8×	0.8×	0.9×	0.9×	—	—
Cash ratio	0.1×	0.1×	0.1×	0.1×	0.1×	0.3×	0.3×	+0.0%
Asset turnover	0.5×	0.5×	0.5×	0.5×	0.6×	0.5×	—	—
Inventory turnover	3.0×	1.9×	1.8×	1.5×	1.5×	2.1×	—	—
Receivables turnover	1.8×	3.5×	3.9×	3.8×	3.9×	4.1×	—	—
Dividend payout	0.0%	13.3%	−35.9%	0.0%	15.9%	−5.7%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.